Sonoma Pharma jumps on launching UTI treatment in three new markets

Sonoma Pharmaceuticals

30/03/2022 14:26

** Shares of healthcare company  SNOA.O  jump 17.8% to $3.96
premarket
    ** Co launches its urinary tract infection catheter and
bladder rinse, Microdox, in New Zealand, Australia and South
Africa   urn:newsml:reuters.com:*:nBw1Yws7Sa
    ** Microdox is intended to treat and prevent infections in
urinary tract and bladder
    ** It is a non-irritating and non-toxic solution based on
co's patented Microcyn Technology and is ready for immediate use
- SNOA
    ** Microdox is available through SNOA partners, Te Arai
BioFarma in New Zealand and Australia, and through NuAngle in
South Africa
    ** SNOA down ~26.3% YTD

 (Reporting by Mrinalika Roy in Bengaluru)
 ((mrinalika.roy@thomsonreuters.com; within U.S. +1 646 223
8780, outside U.S. +91 806749 8325;))